ResearcherMedical University of South CarolinaNo recent work listed

Paul E. O’Brien

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3348-127X; OpenAlex author ID A5102970062. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2012: 1 trial · 2013: none · 2014: 1 paper

Papers 1

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectab… Co-author DOI 10.1016/j.ijrobp.2013.12.030 ↗

Trials 1

Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma Principal investigator NCT01677988 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

David J. Cole · 1 shared paper, 2014 · strength 0.04
- Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030 ↗
Ernest Ramsay Camp · 1 shared paper, 2014 · strength 0.04
- Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030 ↗
Nestor F. Esnaola · 1 shared paper, 2014 · strength 0.04
- Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030 ↗
David T. Marshall · 1 shared paper, 2014 · strength 0.04
- Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030 ↗
Alberto J. Montero · 1 shared paper, 2014 · strength 0.04
- Paper Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiat… DOI 10.1016/j.ijrobp.2013.12.030 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.